Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 4 matching records
IGF::OT::IGF TITLE: CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY EFFECTIVE DATE: 9/19/2014 PERIOD OF PERFORMANCE: 9/19/2014-9/18/2017Department of Health and Human Services$743.4K obligationsEnds Jan 31, 2022
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND…Department of Health and Human Services$62.9K obligationsEnds Jul 31, 2027
OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIALDepartment of Health and Human Services$349.3K obligationsEnds May 30, 2025
IGF::OT::IGF A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL…Department of Health and Human Services$1.4M obligationsEnds Mar 31, 2022